Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.36 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.36 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL655143 | 0.97 | SMN1; SMN2 (0.46) | SMN1; SMN2CA14ALDH1A1CA12KMT2A | |
| SCHEMBL10458392 | 0.87 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14ALDH1A1CA12KMT2A | |
| SCHEMBL2561278 | 0.85 | — | — | |
| SCHEMBL2930776 | 0.85 | — | — | |
| SCHEMBL27554292 | 0.85 | — | — | |
| SCHEMBL27833677 | 0.85 | — | — | |
| SCHEMBL24016832 | 0.84 | GAA (0.44) | SMN1; SMN2ALDH1A1KMT2ACA1CA2 | |
| Hydrochloric Acid SCHEMBL2840092 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14ALDH1A1CA12KMT2A | |
| SCHEMBL12216178 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL5987780 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14ALDH1A1CA12KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | claimed |
| CN-115304516-A | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2022-11-08 | — | — | CN | claimed |
| US-20260109840-A1 | SOLID POLYELECTROLYTE COMPLEX-BASED PLASTICS FROM MODIFIED BIOPOLYMERS | UNIV CHICAGO (US) | 2026-04-23 | — | — | US | disclosed |
| CN-118239879-A | Method for preparing 3-substituted oxindole, dihydroisoindigo and tetra-substituted ethane based on primary amine and application of primary amine | 泰山学院 | 2024-06-25 | — | — | CN | disclosed |
| CN-115304516-B | Compounds with unconventional chromophores, their preparation and use | 四川大学 | 2024-04-30 | — | — | CN | disclosed |
| CN-117843517-A | Preparation method of impurity valeramide of imidazole aldehyde | 云南云天化股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| CN-220159937-U | Hydrogen chloride gas recycling and applying device in imidazole aldehyde continuous production | 云南云天化股份有限公司 | 2023-12-12 | — | — | CN | disclosed |
| WO-2023107623-A2 | BICYCLIC HETEROARENES AND METHODS OF THEIR USE | Kineta, Inc. (US) | 2023-06-15 | — | — | WO | disclosed |
| US-20230098076-A1 | A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE, 3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOF | COUNCIL OF SCIENT AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN (IN) | 2023-03-30 | — | — | US | disclosed |
| US-11529760-B2 | Polymeric materials and articles manufactured there from | THE PROCTER & GAMBLE COMPANY (US) | 2022-12-20 | — | — | US | disclosed |
| CN-113336667-B | Method suitable for industrial production of intermediate of roxasistat | 南京正济医药研究有限公司 | 2022-12-13 | — | — | CN | disclosed |
| EP-0275480-A2 | Renin inhibitors IV | WARNER-LAMBERT COMPANY (US) | 1988-07-27 | — | — | EP | disclosed |
| US-4719288-A | HYPOTENSIVE | CIBA-GEIGY CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| US-4613676-A | PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1986-09-23 | — | — | US | disclosed |
| US-4595532-A | N-(substituted-methyl)-azetidin-2-ones | UNIVERSITY OF NOTRE DAME DU LAC (US) | 1986-06-17 | — | — | US | disclosed |
| US-4510141-A | (1,2,4) TRIAZOLO(1,5-A) QUINOXALINE OR PYRIDO(2,3-E)(U,2,4)TRIAZOLO(1,5-A)PYRAZINE COMPOUNDS | CIBA-GEIGY CORPORATION (US) | 1985-04-09 | — | — | US | disclosed |
| EP-0116432-A2 | Improvements in or relating to N-(substituted-methyl)-azetidin-2-ones | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1984-08-22 | — | — | EP | disclosed |
| US-4130717-A | Process and intermediates for isoindole derivatives | HOFFMANN-LA ROCHE INC. (US) | 1978-12-19 | — | — | US | disclosed |
| US-4089875-A | Process and intermediates for isoindole derivatives | HOFFMANN-LA ROCHE INC. (US) | 1978-05-16 | — | — | US | disclosed |
| US-3966793-A | ORTHO-AMINOARYL KETIMINES | CLIN MIDY (FR) | 1976-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098076-A1 | A PROCESS FOR PREPARATION OF 3,6-DICHLOROCYANO PYRAZINE, 3,6-DIOXOPIPERAZINE DERIVATIVES AND PRODUCTION OF FAVIPIRAVIR THEREOF | CBR3, CYP4F3, CYP3A5 | SMN1; SMN2 4197/4885CA14 1892/4885ALDH1A1 3833/4885 |
| US-20260109840-A1 | SOLID POLYELECTROLYTE COMPLEX-BASED PLASTICS FROM MODIFIED BIOPOLYMERS | ALG1, PARN, LCP1 | SMN1; SMN2 3151/4885CA14 380/4885ALDH1A1 2896/4885 |
| US-11529760-B2 | Polymeric materials and articles manufactured there from | ALG3, CD68, VCL | SMN1; SMN2 1266/4885CA14 1491/4885ALDH1A1 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.